GlassScriptPhysician profile
Philip J Dombrowski
NPI 1679672794
$10,032.36
in general payments reported to CMS, 2019-2025
14 companies · $394 in 2025
The $394 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $152 · 2020: $34.75 · 2021: $1,127 · 2022: $141 · 2023: $7,663 · 2024: $520 · 2025: $394.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $7,500 · Food and Beverage: $1,077.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $7,500.00 |
| Food and Beverage | $1,077.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $7,500.00 | 2023 | Auryon Laser System 100-120 Vac |
| Silk Road Medical, INC. | $1,249.32 | 2021-2022 | |
| Stryker Corporation | $379.13 | 2025 | Flowtriever, Clottriever Bold Catheter, Ct Thrombectomy System Kit |
| Boston Scientific Corporation | $200.84 | 2023-2025 | Peripheral Rotalink Plus, Eluvia, Innova Vascular |
| Inari Medical, INC. | $148.66 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic, INC. | $140.15 | 2023-2024 | Symplicity G3, Onyx Frontier, Kyphon Express II Kyphopak Tray |
| Veryan Medical Incorporated | $123.17 | 2024 | Biomimics 3d Vascular Stent System |
| Cook Medical LLC | $104.01 | 2020-2024 | Zenith Spiral-Z |
| Intact Vascular, INC. | $98.16 | 2019 | |
| Endologix LLC | $37.98 | 2019 | |
| Abbott Laboratories | $19.22 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $16.18 | 2023 | Camzyos |
| Ekos Corporation | $15.54 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Dombrowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.